11.01.18
In the 2019 Best Law Firms guide, Manatt practices earned nine Tier 1 national designations and 29 Tier 1 metropolitan acknowledgments.
10.26.18
Manatt’s Ian Spatz, a senior advisor with our Manatt Health team, spoke with Kaiser Health News for an article on the Trump administration’s blueprint to upend the healthcare industry.
10.25.18
Manatt’s Ian Spatz, a senior advisor with our Manatt Health team, was interviewed on a PharmaVoice podcast about the effectiveness of the potential drug price transparency requirement.
10.22.18
Manatt’s Jack Quinn, a partner in the firm’s government and regulatory practice, was interviewed as part of CNN’s political forum, CITIZEN.
10.19.18
Manatt’s Cindy Mann, a partner with our Manatt Health team, was quoted in Healthcare Dive in an article about Medicaid’s popularity.
10.18.18
Manatt’s Jack Quinn, a partner in the firm’s government and regulatory practice, was interviewed by CNN about the frequency with which Paul Manafort has met with Robert Mueller’s team in the past few weeks.
10.16.18
Manatt’s Ian Spatz, a senior advisor with our Manatt Health team, was interviewed by Bloomberg Law: Health Law & Business for an article on the Trump’s administration’s proposal challenging the pharmaceutical industry.
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with Inside Health Policy for an article on the Centers for Medicare & Medicaid Services’ proposal.
10.08.18
Manatt’s Ian Spatz, a senior advisor with our Manatt Health team, was quoted by the Los Angeles Times in an article on California’s call for drug pricing transparency.
10.04.18
Manatt’s Jack Quinn, a partner in the firm’s government and regulatory practice, was interviewed by CNN about the supplemental FBI investigation into Supreme Court nominee Brett Kavanaugh.
